chr11-19182672-ATTCT-A
Variant summary
The NM_003476.5(CSRP3):c.579_582delAGAA (p.Lys193AsnfsTer14) variant causes a frameshift change. This is a loss-of-function variant that does not trigger NMD. The gene CSRP3 is a known oncogene (CancerMine: 1 oncogene citations). Note: allele frequency estimates from gnomAD may be inaccurate for this variant type (MNP or indel longer than 3 bp) due to technology limitations. The variant allele was found at a cumulative frequency of 0.000000684 (AC=1) in the gnomAD database across 1,461,808 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000899. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain Significance (★★).
Frequency
Consequence
NM_003476.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 12Inheritance: AR, AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hypertrophic cardiomyopathyInheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathy 1MInheritance: AD Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- familial dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2]) | ||
| O9Protein length change in non-repeat region | Truncating variant in final exon of oncogene — predicted GOF (O9 moderate); Truncating variant in final exon of oncogene — predicted to escape NMD and result in GOF |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_003476.5. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CSRP3 | MANE Select | c.579_582delAGAA p.Lys193AsnfsTer14 | frameshift | Exon 6 of 6 | Prot: NP_003467.1 | |
CSRP3 | c.410_413delAGAA p.Lys137MetfsTer19 | frameshift | Exon 5 of 5 | Prot: NP_001356333.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CSRP3 | TSL:1MANE Select | c.579_582delAGAA p.Lys193AsnfsTer14 | frameshift | Exon 6 of 6 | Prot: ENSP00000265968.3 UniProt: | |
CSRP3 | TSL:1 | c.579_582delAGAA p.Lys193AsnfsTer14 | frameshift | Exon 7 of 7 | Prot: ENSP00000431813.1 UniProt: | |
CSRP3 | c.588_591delAGAA p.Lys196AsnfsTer14 | frameshift | Exon 6 of 6 | Prot: ENSP00000621129.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 3 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | AF: 6.84e-7 | AC:1 | Hom:0 | AN:1461808 | |
GnomAD4 genome | Cov:32 | ||||
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.0000238 | 1 | 41958 | 0.0000299 | 2 | 66888 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
PhyloP100 | Uncertain | 4.2 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.